Bhatt Padmanabh P.

Bhatt Padmanabh P., Senior VP of IP and CSO, has demonstrated a clear selling bias in recent transactions involving Supernus Pharmaceuticals (SUPN), the only company in which he has reported trades. Over 34 total transactions, his aggregate sales of $5.56 million outweigh purchases of $3.89 million, with all six of his most recent trades being sales. Between March 16 and March 18, 2026, Bhatt executed multiple high-value disposals, including a $1.38 million sale on March 17 and a $1.71 million sale the prior day. These were supplemented by smaller but still substantial transactions, such as a $338,822 sale on March 18 and an $802,084 sale on March 16. The filings also show derivative transactions marked as dispositions ("D") and acquisitions ("A") with zero reported value in late February 2026, alongside smaller-value transactions classified as gifts or other exempt operations ("F"). The absence of recent buys and the concentration of activity in SUPN suggest a deliberate reduction in his position in the company, though the filings provide no context for the transactions beyond their execution. The scale and timing of these sales—particularly the cluster in mid-March—indicate a significant shift in his holdings during that period.